跳至主要内容
临床试验/NL-OMON40193
NL-OMON40193尚未招募4 期

The effect of low doses of mirtazapine and quetiapine on sleep and daytime functioning. - mirtazapine, quetiapine and sleep

GGZ Drenthe (Assen)0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Non-smoking, male, between the ages of 18 and 35 years.

排除标准

  • Past or present sleeping disorder and/or psychiatric disorder, a family history of sleeping disorder and/or psychiatric disorder, liver disease, cardiovascular disease, alcohol- or substance dependence, medication use (including psychotropic medication), known intolerance for mirtazapine or quetiapine, a BMI of or below 18.5 or of or above 30.

研究者

发起方
GGZ Drenthe (Assen)

相似试验